AstraZeneca in Talks for Potential $400 Billion Merger with Bristol Myers Squibb

AstraZeneca in Talks for Potential $400 Billion Merger with Bristol Myers Squibb

AstraZeneca is reportedly in discussions for a potential merger with Bristol Myers Squibb, a deal that could create one of the world's largest pharmaceutical companies valued at approximately $400 billion.

Comments

Read this story in other languages

es nl tr fr de it

DOWNLOAD OUR APP

Cupure iOS App

Download on the App Store

App Store QR Code

GET IT ONGoogle Play

Google Play QR Code

Similar News from External Sources

Dailymailen·1mo
AstraZeneca holds talks with Bristol Myers Squibb over £300bn merger
the Guardianen·1mo
AstraZeneca holds talks with Bristol Myers Squibb on $400bn merger
Financial Timesen·1mo
FirstFT: AstraZeneca and Bristol Myers Squibb discuss $400bn tie-up
la vangardiaes·1mo
AstraZeneca y Bristol Myers Squibb estudian una fusión de 400.000 millones de dólares
Sud Ouestfr·1mo
Pharmacie : AstraZeneca et Bristol Myers Squibb envisagent une fusion à 400 milliards de dollars
Süddeutsche Zeitungit·1mo
Pharmabranche: Insider: Mega-Fusion zwischen Astra Zeneca und Bristol Myers im Gespräch
Wirtschaftswochede·1mo
Pharmaindustrie: Mega-Fusion zwischen AstraZeneca und Bristol Myers im Gespräch
Il Sole 24 Oreit·1mo
Ft: AstraZeneca tratta con Bristol Myers Squibb maxi fusione da 400 miliardi